References
- Coelingh Bennink H JT. The pharmacokinetics of Implanon®, single rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000; 5(suppl 2)12–20
- Bitzer J, Tschudin S, Alder J, the Swiss Implanon® Study Group. Acceptability and side effects of Implanon® in Switzerland: A retrospective study by the Implanon® Swiss study Group. Eur J Contracept Reprod Health Care 2004; 9: 278–284
- Reuter S, Smith A. Implanon®: user views in the first year across three family planning services in the Trent Region, UK. Eur J Contracept Reprod Health Care 2003; 8: 27–36
- Croxatto H B. Clinical profile of Implanon®: A single rod etonogestrel implant. Eur J Contracept Reprod Health Care 2000; 5(suppl 2)21–28
- Darney P D. Implantable contraception. Eur J Contracept Reprod Health Care 2000; 5(suppl 2)2–11
- Lapido O A, Akinso S A. Contraceptive implants ‘review article’. Afr J Reprod Health 2005; 9: 16–23
- Edwards J F, Moore A. Implanon®. A review of clinical studies. Br J Fam Plann 1999; 24: 3–16
- Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon®. Contraception 1998; 58: 99–107
- Nilpetchploy S, Taneepanichskul S. Effects of a single rod etonogestrel used in healthy Thai women aged between 17 and 35 years in King Chulalongkorn Memorial Hospital. Thai J Obstet Gynecol 2002; 14: 291–295
- Brache V, Faundes A, Alvarez F, Cochon L. Non-menstrual adverse events during use of implantable contraceptives for women: Data from clinical trials. Contraception 2002; 65: 63–74
- Croxatto H B, Urbancsek J, Massai R, , the Implanon® Study Group, et al. A multicenter efficacy and safety study on the single contraceptive implant Implanon®. Hum Reprod 1999; 14: 976–981
- Evans R, Holman R, Lindsay E. Migration of Implanon®: Two case reports. J Fam Plann Reprod Health Care 2005; 31: 71–72